Palladia - 15mg Palladia Tablets for Dogs - Per Tablet
337535
15mg Palladia for Dogs - Treatment for Canine Mast Cell Tumours
Mast cell tumours, a common type of cancer in dogs, account for a large portion of all canine skin tumours. These malignant growths originate from mast cells, a type of white blood cell. Early detection and proper treatment are vital in managing this condition, and 15mg Palladia for dogs offers a highly effective solution.
Palladia 15mg for dogs works by targeting specific proteins involved in the growth and spread of cancerous cells. The drug inhibits the activity of these proteins, effectively stopping tumour progression. This targeted approach allows 15mg Palladia to attack cancerous cells while sparing healthy ones, minimising overall side effects on your pet.
VET PRESCRIPTION REQUIRED
Product Features
- Pack Size: - Sold Individually
- Target Animal: - Dog (Canine)
- Related Condition: - Mast cell tumours in dogs
- Pet Prescription Required?: - Yes (For UK Orders)
- Active Ingredient: - Toceranib Phosphate
- Product Name: - 15mg Palladia Tablets for Dogs
More Information
Description
15mg Palladia Tablets for Dogs - Effective treatment for canine mast cell tumours.
Palladia may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase Palladia if you have or are in the process of arranging such a prescription. See information bar for further details.
15mg Palladia tablets for dogs contain 15mg Toceranib phosphate. Each Palladia tablet is round in shape, marked with the Pfizer logo on one side and the strength on the other. The 15mg Palladia tablet is orange.
Palladia is used for the treatment of non-resectable Patnaik grade II (intermediate grade) or III (high grade), recurrent, cutaneous mast cell tumours in dogs.
Dosage and administration
For oral use.
15mg Palladia tablets can be administered with or without food.
The initial recommended dose of Palladia is 3.25 mg/kg bodyweight, administered every second day (see dosing table for details).
Research and clinical trials have demonstrated the efficacy of 15mg Palladia for dogs in treating mast cell tumors. Many cases have shown significant tumour reduction, and in some instances, complete tumour regression. This makes 15mg Palladia an invaluable treatment option for dogs battling mast cell tumors. With our emphasis on fast delivery, you can trust that your pet will receive this powerful medication in a timely manner, giving them the best chance for a swift recovery.
The dose given should be based on veterinary assessments conducted weekly for the first six weeks and, thereafter, every six weeks. Duration of treatment depends on the response to treatment.
Treatment should continue in the case of stable disease, or partial or complete response, provided that the product is sufficiently well tolerated. In case of tumour progression, treatment is unlikely to be successful and should be reviewed.
formed with toceranib. No information relating to potential cross resistance with other cytostatic products is available.
As toceranib is eliminated to a large extent by metabolism in the liver, the combination with other drugs capable of inducing or inhibiting liver enzymes should be used with caution.
Do not use after the expiry date stated on the carton.
Palladia does not require any special storage conditions.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Keep out of the reach and sight of children.
For animal treatment only.
Legal category
Palladia 15mg is a POM-V (Pet Prescription Required)
